First Time Loading...

Adagene Inc
NASDAQ:ADAG

Watchlist Manager
Adagene Inc Logo
Adagene Inc
NASDAQ:ADAG
Watchlist
Price: 2.12 USD -2.75%
Updated: May 10, 2024
Section:
 

Wall Street
Price Targets

ADAG Price Targets Summary
Adagene Inc

Wall Street analysts forecast ADAG stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ADAG is 12.24 USD with a low forecast of 5.05 USD and a high forecast of 27.3 USD.

ADAG Lowest Forecast
Wall Street Target
5.05 USD
138% Upside
ADAG Average Forecast
Wall Street Target
12.24 USD
477% Upside
ADAG Highest Forecast
Wall Street Target
27.3 USD
1 188% Upside
Lowest
Price Target
5.05 USD
138% Upside
Average
Price Target
12.24 USD
477% Upside
Highest
Price Target
27.3 USD
1 188% Upside

ADAG Last Price Targets
Adagene Inc

The latest public price target was made on Apr 8, 2024 by Matthew Harrison from Morgan Stanley , who expects ADAG stock to rise by 136% over the next 12 months. You can read more about this price target by viewing the article on StreetInsider.

Analyst Price Target Date Article
Matthew Harrison
Morgan Stanley
5 USD
Upside 136%
1 month ago
Apr 8, 2024
Adagene Inc (ADAG) PT Raised to $5 at Morgan Stanley
StreetInsider
Matthew Harrison
Morgan Stanley
Price Target 5 USD
Upside/Downside 136%
View Source
Adagene Inc Competitors:
Price Targets
300439
MedicalSystem Biotechnology Co Ltd
124% Upside
688520
Sinocelltech Group Ltd
42% Upside
688366
Shanghai Haohai Biological Technology Co Ltd
39% Upside
LYEL
Lyell Immunopharma Inc
141% Upside
300439
MedicalSystem Biotechnology Co Ltd
124% Upside
688520
Sinocelltech Group Ltd
42% Upside
688366
Shanghai Haohai Biological Technology Co Ltd
39% Upside
LYEL
Lyell Immunopharma Inc
141% Upside
BIIB
Biogen Inc
31% Upside
KOD
Kodiak Sciences Inc
14% Upside
GTH
Genetron Holdings Ltd
67% Downside
VRTX
Vertex Pharmaceuticals Inc
13% Upside

Revenue
Forecast

Revenue Estimate
Adagene Inc

For the last 4 years the compound annual growth rate for Adagene Inc's revenue is 148%.

148%
Past Growth
N/A
Estimated Growth
Estimates Accuracy
3%
Average Beat
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Adagene Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-8%
Average Miss
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Adagene Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-27%
Average Miss
What are analyst estimates?

See Also

Summary
ADAG intrinsic value, competitors valuation, and company profile.
DCF Valuation
ADAG stock valuation using Discount Cash Flow valuation method.
Relative Valuation
ADAG stock valuation using valuation multiples.
Wall Street Estimates
ADAG price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
ADAG stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is ADAG's stock price target?
Price Target
12.24 USD

According to Wall Street analysts, the average 1-year price target for ADAG is 12.24 USD with a low forecast of 5.05 USD and a high forecast of 27.3 USD.

ALPHA SPREAD
Join more than 136,000+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.